Xianglin Yuan

11.4k total citations · 1 hit paper
233 papers, 5.0k citations indexed

About

Xianglin Yuan is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xianglin Yuan has authored 233 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Molecular Biology, 88 papers in Oncology and 77 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xianglin Yuan's work include Effects of Radiation Exposure (26 papers), Lung Cancer Treatments and Mutations (23 papers) and Cancer Immunotherapy and Biomarkers (22 papers). Xianglin Yuan is often cited by papers focused on Effects of Radiation Exposure (26 papers), Lung Cancer Treatments and Mutations (23 papers) and Cancer Immunotherapy and Biomarkers (22 papers). Xianglin Yuan collaborates with scholars based in China, United States and United Kingdom. Xianglin Yuan's co-authors include Dominic M. Desiderio, Hong Qiu, Tingting Huang, Bo Liu, Zhongxing Liao, Huihua Xiong, Li Sun, Junbo Hu, Robert L. Mauck and Rocky S. Tuan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xianglin Yuan

216 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer

2018 515 citations Jingqin Lan, Li Sun et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xianglin Yuan China	36	2.3k	1.2k	1.1k	1.0k	633	233	5.0k
Anil Vachani United States	43	1.5k 0.6×	2.1k 1.7×	2.7k 2.4×	843 0.8×	746 1.2×	193	6.0k
Michael Fiegl Austria	37	2.3k 1.0×	1.9k 1.5×	852 0.8×	1.1k 1.1×	841 1.3×	165	5.9k
Michael Neumaier Germany	42	2.2k 0.9×	1.6k 1.3×	631 0.6×	730 0.7×	914 1.4×	220	6.5k
Jonathan Waxman United Kingdom	47	3.3k 1.4×	1.4k 1.1×	1.5k 1.3×	1.3k 1.3×	455 0.7×	178	6.5k
Anna Lokshin United States	48	2.3k 1.0×	2.4k 1.9×	970 0.9×	1.1k 1.1×	1.7k 2.7×	137	6.7k
Yoshihiro Nishimura Japan	38	1.5k 0.6×	1.0k 0.8×	2.2k 2.0×	521 0.5×	388 0.6×	277	5.2k
Ondřej Topolčan Czechia	31	1.3k 0.6×	1.6k 1.3×	1.0k 0.9×	1.1k 1.1×	292 0.5×	254	4.2k
Ronald Rodríguez United States	36	2.8k 1.2×	1.1k 0.9×	1.5k 1.3×	520 0.5×	365 0.6×	153	4.7k
Kazutoshi Fujita Japan	39	2.1k 0.9×	892 0.7×	1.6k 1.4×	1.0k 1.0×	356 0.6×	262	5.1k
Zhen Zhang China	41	1.9k 0.8×	1.8k 1.5×	1.9k 1.7×	1.6k 1.6×	399 0.6×	307	6.6k

Countries citing papers authored by Xianglin Yuan

Since Specialization

Citations

This map shows the geographic impact of Xianglin Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianglin Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianglin Yuan more than expected).

Fields of papers citing papers by Xianglin Yuan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianglin Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianglin Yuan. The network helps show where Xianglin Yuan may publish in the future.

Co-authorship network of co-authors of Xianglin Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Xianglin Yuan. A scholar is included among the top collaborators of Xianglin Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianglin Yuan. Xianglin Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Sheng, et al.. (2025). Radiation-induced lung injury: from mechanism to prognosis and drug therapy. Radiation Oncology. 20(1). 39–39. 1 indexed citations

Zhou, Yuehua, Jingyao Tu, Sidan Tian, et al.. (2025). A Bifunctional Antibody Targeting PD-1 and TGF-β Signaling Has Antitumor Activity in Combination with Radiotherapy and Attenuates Radiation-Induced Lung Injury. Cancer Immunology Research. 13(5). 767–784. 1 indexed citations

Wei, Jia, Lei Tang, Sijian Wang, et al.. (2025). TLR4 identified as a major depressive disorder gene signature mediating effects through multiple immune cells. Scientific Reports. 15(1). 12437–12437. 2 indexed citations

Chen, Xinyi, et al.. (2025). Molecular mechanisms underlying the abscopal effect induced by radiotherapy and its synergistic translational potential with immunotherapy. Therapeutic Advances in Medical Oncology. 17. 22832270–22832270. 1 indexed citations

Li, Qinyu, Kai Zeng, Chenglin Han, et al.. (2024). Atractylenolide I inhibits angiogenesis and reverses sunitinib resistance in clear cell renal cell carcinoma through ATP6V0D2-mediated autophagic degradation of EPAS1/HIF2α. Autophagy. 21(3). 619–638. 8 indexed citations

Chen, Junjie, et al.. (2024). Advances in the therapeutic study of oncolytic virus in colorectal cancer. Oncology and Translational Medicine. 10(4). 171–177. 3 indexed citations

Chen, Xinyi, et al.. (2024). MUC1 and MUC16: critical for immune modulation in cancer therapeutics. Frontiers in Immunology. 15. 1356913–1356913. 23 indexed citations

Ma, Li, Xinyi Chen, Yulong Yu, et al.. (2024). TNKS1BP1 facilitates ubiquitination of CNOT4 by TRIM21 to promote hepatocellular carcinoma progression and immune evasion. Cell Death and Disease. 15(7). 511–511. 8 indexed citations

Li, Chunya, Jingyao Tu, Chaofan Liu, et al.. (2024). ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC Class I. Cell Death and Disease. 15(7). 519–519. 13 indexed citations

10.

Zhang, Lei, Siyuan Wang, Guorao Wu, et al.. (2023). MBD2 facilitates tumor metastasis by mitigating DDB2 expression. Cell Death and Disease. 14(5). 303–303. 4 indexed citations

11.

Jin, Meng, Bo Liu, Yongbiao Huang, et al.. (2023). Genome-Wide Splicing Quantitative Expression Locus Analysis Identifies Causal Risk Variants for Non–Small Cell Lung Cancer. Cancer Research. 83(10). 1742–1756. 10 indexed citations

12.

Liu, Bo, et al.. (2023). A bibliometric analysis of research on R-loop: Landscapes, highlights and trending topics. DNA repair. 127. 103502–103502. 5 indexed citations

13.

Chen, Xinyi, Jingyao Tu, Li Ma, et al.. (2022). Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma. SHILAP Revista de lepidopterología. 9 indexed citations

14.

Qin, Shukui, Jin Li, Haijun Zhong, et al.. (2022). Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial. British Journal of Cancer. 127(12). 2241–2248. 15 indexed citations

15.

Wang, Yali, Hua Xiong, Yongbiao Huang, et al.. (2021). PARP Inhibitor Upregulates PD-L1 Expression and Provides a New Combination Therapy in Pancreatic Cancer. Frontiers in Immunology. 12. 30 indexed citations

16.

Lan, Jingqin, Li Sun, Feng Xu, et al.. (2018). M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer. Cancer Research. 79(1). 146–158. 515 indexed citations breakdown →

17.

Wang, Junfeng, et al.. (2016). Simulation and application of 3D printed compensator in electron radiation therapy for Merkel cell carcinoma. Zhonghua fangshe zhongliuxue zazhi. 25(9). 999–1002. 1 indexed citations

18.

Li, Qianxia, Ju Dong Yang, Qianqian Yu, et al.. (2013). Associations between Single-Nucleotide Polymorphisms in the PI3K–PTEN–AKT–mTOR Pathway and Increased Risk of Brain Metastasis in Patients with Non–Small Cell Lung Cancer. Clinical Cancer Research. 19(22). 6252–6260. 60 indexed citations

19.

Crabb, John W., et al.. (2009). Pentosidine and Carboxymethyllysine, Plasma Biomarkers for Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 50(13). 2330–2330. 3 indexed citations

20.

Yuan, Xianglin, et al.. (2009). Quantitative Proteomic Analysis of Uveal Melanoma Tissues. Investigative Ophthalmology & Visual Science. 50(13). 499–499. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact